Application no. and date | 02738961.8 (espacenet) (Federated) (European Patent Register), 20020523 | Patent/reg. no. and date | DK/EP 1390042, 20071128 | Publication date | 20040225 | Priority no. and date | EP 01201946, 20010523, EP 01201945, 20010523, EP 01201947, 20010523, EP 01204377, 20011115, EP 02075695, 20020221 | EP pub. no. and date |
EP 1390042 20040225 | Effective date | | Applicant/owner | ESTETRA SRL, Rue Saint-Georges 5
B-4000 Liège, BE | Applicant ref. no. | 75947DK01 | Inventor | HOLINKA, Christian, Franz, 299 West 12th Street - 97
New York, NY 10014, US, COELINGH BENNINK, Herman, Jan, Tijmen, Melvill van Carnbeelaan 38
NL-3971 BE Driebergen, NL, BUNSCHOTEN, Evert, Johannes, Plantsoen 16
NL-5384 EV Heesch, NL | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/567 (2006.01) , A61K 31/57 (2006.01) , A61P 15/18 (2006.01) | Title | System for administration af et lægemiddel omfattende tetrahydroxyleret østrogen til anvendelse i hormonal svangerskabsforebyggelse | Int. application no. | NL2002000331 | Int. publication no. | WO2002094279 | Related patent (certificate) | CA 2021 00028 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|